BALTIMORE and PALO ALTO, Calif., April 25, 2025 /PRNewswire/ -- DELFI Diagnostics, Inc., developer of innovative blood-based tests that leverage cell-free DNA (cfDNA) fragmentomics for cancer ...
Endometrial cancer is one of the most common cancers in Australian women—and one of the hardest to catch. But a new breakthrough in AI cancer detection is pushing accuracy levels to an unprecedented ...
BURLINGTON, Mass. and PALO ALTO, Calif., Nov. 19, 2024 /PRNewswire/ -- DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new way to enhance cancer detection, has ...
DELFI Diagnostics has clinically validated FirstLook Lung, its blood test designed to improve early detection of lung cancer, which remains the leading cause of cancer deaths in the United States. At ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback